Bachem Holding AG ( (CH:BANB) ) has issued an announcement.
Bachem Holding AG announced that its Annual General Meeting 2025 approved all proposals from the Board of Directors, including a dividend of CHF 0.85 per share, to be paid on May 7, 2025. The meeting also saw the re-election of the President and Board members, the election of Dr. Simone Wyss Fedele to the Board, and the approval of various financial and sustainability reports. Forvis Mazars SA was appointed as the auditor for 2025. This approval reflects strong shareholder support and positions Bachem for continued stability and growth in the pharmaceutical and biotech sectors.
More about Bachem Holding AG
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With a comprehensive range of services, Bachem offers pharmaceutical and biotech companies worldwide products for research, clinical development, and commercial application. Headquartered in Switzerland with locations in Europe, the USA, and Asia, Bachem operates internationally and has more than 50 years of experience and industry-leading expertise. The company is listed on the SIX Swiss Exchange.
YTD Price Performance: -14.21%
Average Trading Volume: 20,841
Technical Sentiment Signal: Buy
Current Market Cap: CHF3.74B
For an in-depth examination of BANB stock, go to TipRanks’ Stock Analysis page.